According to a St. Louis Post-Dispatch story, Monsanto “is beginning in-house production of Posilac, which should ease a two-year-old shortage of the hormone used to boost milk production in cows.”

The story goes on to say that although “Monsanto does not release Posilac market data . . . it sells more than 33 million doses a year.” The hormone product will be made at the company’s Augusta, GA facility.